Page last updated: 2024-10-31

mitotane and Hyperandrogenism

mitotane has been researched along with Hyperandrogenism in 2 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Hyperandrogenism: A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chortis, V1
Johal, NJ1
Bancos, I1
Evans, M1
Skordilis, K1
Guest, P1
Cullen, MH1
Porfiri, E1
Arlt, W1
Sedhom, R1
Hu, S1
Ohri, A1
Infantino, D1
Lubitz, S1

Other Studies

2 other studies available for mitotane and Hyperandrogenism

ArticleYear
Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess.
    European journal of endocrinology, 2018, Volume: 178, Issue:3

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgens; Antineoplastic Agents, Hormonal; Gas Chromatograph

2018
Symptomatic Cushing's syndrome and hyperandrogenemia in a steroid cell ovarian neoplasm: a case report.
    Journal of medical case reports, 2016, Oct-12, Volume: 10, Issue:1

    Topics: Aged; Antineoplastic Agents, Hormonal; Cushing Syndrome; Disease Progression; Fatal Outcome; Female;

2016